Molecular diagnosis and genetic counseling for fragile X mental retardation

被引:0
作者
Pandey, UB [1 ]
Phadke, SR [1 ]
Mittal, B [1 ]
机构
[1] Sanjay Gandhi Postgrad Inst Med Sci, Dept Med Genet, Lucknow 226014, Uttar Pradesh, India
关键词
fragile X mental retardation; genetic counseling; mutation; premutation;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The fragile X syndrome is the most frequent cause of inherited mental retardation. It is caused by a dynamic mutation: the progressive expansion of polymorphic (CGG)n trinucleotide repeats located in the promoter region of the FMRI gene at Xq27.3. The cloning of the FMRI gene and the elucidation of the molecular basis of the fragile X syndrome is of great importance for the diagnosis and understanding of this unusual type of mutation. Although extensively studied, the mechanism behind the transition from stable normal (CGG)n alleles to the carrier state (an unstable premutation) and from premutation to mutation is partially understood. The clinical diagnosis of fragile X mental retardation (FXMR) is not possible as dysmorphic features are subtle. Molecular diagnosis by Southern Blot is the confirmatory test that makes carrier detection and prenatal diagnosis possible. As the risk of recurrence of FXMR is high in the family and carrier relatives, an identification of fragile X positive children, and offering carrier detection and prenatal diagnosis to the families is very important. It is possible by screening mentally retarded children and adults even if there is no family history of mental retardation or typical behavioral or physical features associated with the fragile X phenotype. In this review we have discussed the method for the diagnosis and counseling of the families. The complexities due to premutation and the variable severity of manifestations in carrier females need to be understood while counseling fragile X families.
引用
收藏
页码:36 / 42
页数:7
相关论文
共 81 条
[1]   AUTISM IS ASSOCIATED WITH THE FRAGILE-X SYNDROME [J].
BROWN, WT ;
JENKINS, EC ;
FRIEDMAN, E ;
BROOKS, J ;
WISNIEWSKI, K ;
RAGUTHU, S ;
FRENCH, J .
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 1982, 12 (03) :303-308
[2]  
Chiurazzi P, 1996, AM J MED GENET, V64, P203, DOI 10.1002/(SICI)1096-8628(19960712)64:1<203::AID-AJMG37>3.0.CO
[3]  
2-P
[4]   FMR1 and the fragile X syndrome:: Human genome epidemiology review [J].
Crawford, DC ;
Acuña, JM ;
Sherman, SL .
GENETICS IN MEDICINE, 2001, 3 (05) :359-371
[5]  
CURFS L M G, 1991, Genetic Counseling, V2, P55
[6]  
deVries BBA, 1996, AM J HUM GENET, V58, P1025
[7]   THE FMR-1 PROTEIN IS CYTOPLASMIC, MOST ABUNDANT IN NEURONS AND APPEARS NORMAL IN CARRIERS OF A FRAGILE X PREMUTATION [J].
DEVYS, D ;
LUTZ, Y ;
ROUYER, N ;
BELLOCQ, JP ;
MANDEL, JL .
NATURE GENETICS, 1993, 4 (04) :335-340
[8]  
DUNN HG, 1963, AM J MENT DEF, V67, P827
[9]   TRANSMISSION OF FRAGILE (X)(Q27) FROM NORMAL MALE(S) [J].
FRYNS, JP ;
VANDENBERGHE, H .
HUMAN GENETICS, 1982, 61 (03) :262-263
[10]   VARIATION OF THE CGG REPEAT AT THE FRAGILE-X SITE RESULTS IN GENETIC INSTABILITY - RESOLUTION OF THE SHERMAN PARADOX [J].
FU, YH ;
KUHL, DPA ;
PIZZUTI, A ;
PIERETTI, M ;
SUTCLIFFE, JS ;
RICHARDS, S ;
VERKERK, AJMH ;
HOLDEN, JJA ;
FENWICK, RG ;
WARREN, ST ;
OOSTRA, BA ;
NELSON, DL ;
CASKEY, CT .
CELL, 1991, 67 (06) :1047-1058